InvestorsHub Logo
Followers 24
Posts 883
Boards Moderated 0
Alias Born 02/28/2017

Re: None

Thursday, 06/20/2019 8:04:25 AM

Thursday, June 20, 2019 8:04:25 AM

Post# of 54907
More news. Could be big. Is this related to thermo news yesterday

https://finance.yahoo.com/news/predictive-technology-group-announces-presentation-120000805.html

Predictive Technology Group Announces the Presentation of New Genetic Findings in Endometriosis at the 35th Annual Meeting of the European Society of Human Reproduction and Embryology


SALT LAKE CITY, June 20, 2019 (GLOBE NEWSWIRE) -- Predictive Laboratories, a wholly owned subsidiary of Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical intervention through precision therapeutic treatments, announces that Kenneth Ward, M.D. will present new genetic findings in endometriosis at the 2019 European Society of Human Reproduction and Embryology (ESHRE) meeting on Monday, June 24 in Vienna, Austria.

Dr. Ward is CEO of Juneau Biosciences, Laboratory Director of Predictive Laboratories and a member of the Predictive Technology Group Scientific Advisory Board. Predictive Technology Group inlicensed the technology supporting its ARTGuide® Test for endometriosis and other genetic causes of infertility from Juneau Biosciences and is Juneau Biosciences’ largest shareholder.

“Predictive is committed to understanding the biology, diagnosis and treatment of endometriosis,” said Bradley Robinson, President and CEO of Predictive Technology Group. “We are thrilled to contribute to the scientific understanding of a disease that has been difficult to treat and believe our investigative efforts will lead to improved patient outcomes in the future.”

Details on the presentation at ESRHE 2019 are as follows:

Abstract Title: Excess Germline Mutations in Four Genes in Unrelated Women with Surgical Endometriosis

Presenting Author: Dr. Kenneth Ward

Presentation Details: Monday, June 24 at 15:30 CEST
Session 23
Room: Strauss 1+2
A press release summarizing the presented data will be issued following the presentation at ESHRE.